Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysis
Objective: To evaluate the cost utility of epidermal growth factor receptor (EGFR) testing plus first-line gefitinib treatment in patients with activating EGFR mutations in Thailand. Methods: The study used a decision tree model considering the provider's perspective. Direct medical costs were...
Saved in:
Main Authors: | Unchalee Permsuwan, Narawadee Niamhun, Narumon Tanatip, Sumitra Thongprasert |
---|---|
Format: | Journal |
Published: |
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897471037&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/45242 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysis
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand
by: Unchalee Permsuwan, et al.
Published: (2020) -
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
by: De Lima Lopes Jr., G., et al.
Published: (2016) -
Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian Lung adenocarcinomas
by: Toh, C.-K., et al.
Published: (2014) -
The relationship between Epidermal Growth Factor Receptor (EGFR) mutation and computed tomography findings in lung adenocarcinoma
by: Agnes Septiani, et al.
Published: (2019)